Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment

Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found...

Full description

Bibliographic Details
Main Authors: Yuek Ling Chai, Joyce R. Chong, Ainiah R. Raquib, Xin Xu, Saima Hilal, Narayanaswamy Venketasubramanian, Boon Yeow Tan, Alan P. Kumar, Gautam Sethi, Christopher P. Chen, Mitchell K. P. Lai
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-83601-6
id doaj-b1b12e90137f45e5a30c6c0e5d07ecd7
record_format Article
spelling doaj-b1b12e90137f45e5a30c6c0e5d07ecd72021-02-21T12:36:06ZengNature Publishing GroupScientific Reports2045-23222021-02-0111111110.1038/s41598-021-83601-6Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairmentYuek Ling Chai0Joyce R. Chong1Ainiah R. Raquib2Xin Xu3Saima Hilal4Narayanaswamy Venketasubramanian5Boon Yeow Tan6Alan P. Kumar7Gautam Sethi8Christopher P. Chen9Mitchell K. P. Lai10Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Raffles Neuroscience Centre, Raffles HospitalSt. Luke’s HospitalCancer Science Institute of Singapore and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of SingaporeDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6)Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found upregulated in vascular diseases as well as in AD. However, its involvement in vascular dementia (VaD) and pre-dementia stages, namely cognitive impairment no dementia (CIND), both of which fall under the spectrum of vascular cognitive impairment (VCI), has yet to be examined. Its correlations with inflammatory cytokines in cognitive impairment also await investigation. 80 subjects with no cognitive impairment (NCI), 160 with CIND and 144 with dementia were included in a cross-sectional study on a Singapore-based memory clinic cohort. All subjects underwent comprehensive clinical, neuropsychological and brain neuroimaging assessments, together with clinical diagnoses based on established criteria. Blood samples were collected and OPN as well as inflammatory cytokines interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF) were measured using immunoassays. Multivariate regression analyses showed significant associations between increased OPN and VCI groups, namely CIND with CeVD, AD with CeVD and VaD. Interestingly, higher OPN was also significantly associated with AD even in the absence of CeVD. We further showed that increased OPN significantly associated with neuroimaging markers of CeVD and neurodegeneration, including cortical infarcts, lacunes, white matter hyperintensities and brain atrophy. OPN also correlated with elevated levels of IL-6, IL-8 and TNF. Our findings suggest that OPN may play a role in both VCI and neurodegenerative dementias. Further longitudinal analyses are needed to assess the prognostic utility of OPN in disease prediction and monitoring.https://doi.org/10.1038/s41598-021-83601-6
collection DOAJ
language English
format Article
sources DOAJ
author Yuek Ling Chai
Joyce R. Chong
Ainiah R. Raquib
Xin Xu
Saima Hilal
Narayanaswamy Venketasubramanian
Boon Yeow Tan
Alan P. Kumar
Gautam Sethi
Christopher P. Chen
Mitchell K. P. Lai
spellingShingle Yuek Ling Chai
Joyce R. Chong
Ainiah R. Raquib
Xin Xu
Saima Hilal
Narayanaswamy Venketasubramanian
Boon Yeow Tan
Alan P. Kumar
Gautam Sethi
Christopher P. Chen
Mitchell K. P. Lai
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Scientific Reports
author_facet Yuek Ling Chai
Joyce R. Chong
Ainiah R. Raquib
Xin Xu
Saima Hilal
Narayanaswamy Venketasubramanian
Boon Yeow Tan
Alan P. Kumar
Gautam Sethi
Christopher P. Chen
Mitchell K. P. Lai
author_sort Yuek Ling Chai
title Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
title_short Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
title_full Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
title_fullStr Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
title_full_unstemmed Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
title_sort plasma osteopontin as a biomarker of alzheimer’s disease and vascular cognitive impairment
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-02-01
description Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found upregulated in vascular diseases as well as in AD. However, its involvement in vascular dementia (VaD) and pre-dementia stages, namely cognitive impairment no dementia (CIND), both of which fall under the spectrum of vascular cognitive impairment (VCI), has yet to be examined. Its correlations with inflammatory cytokines in cognitive impairment also await investigation. 80 subjects with no cognitive impairment (NCI), 160 with CIND and 144 with dementia were included in a cross-sectional study on a Singapore-based memory clinic cohort. All subjects underwent comprehensive clinical, neuropsychological and brain neuroimaging assessments, together with clinical diagnoses based on established criteria. Blood samples were collected and OPN as well as inflammatory cytokines interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF) were measured using immunoassays. Multivariate regression analyses showed significant associations between increased OPN and VCI groups, namely CIND with CeVD, AD with CeVD and VaD. Interestingly, higher OPN was also significantly associated with AD even in the absence of CeVD. We further showed that increased OPN significantly associated with neuroimaging markers of CeVD and neurodegeneration, including cortical infarcts, lacunes, white matter hyperintensities and brain atrophy. OPN also correlated with elevated levels of IL-6, IL-8 and TNF. Our findings suggest that OPN may play a role in both VCI and neurodegenerative dementias. Further longitudinal analyses are needed to assess the prognostic utility of OPN in disease prediction and monitoring.
url https://doi.org/10.1038/s41598-021-83601-6
work_keys_str_mv AT yueklingchai plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT joycerchong plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT ainiahrraquib plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT xinxu plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT saimahilal plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT narayanaswamyvenketasubramanian plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT boonyeowtan plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT alanpkumar plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT gautamsethi plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT christopherpchen plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
AT mitchellkplai plasmaosteopontinasabiomarkerofalzheimersdiseaseandvascularcognitiveimpairment
_version_ 1724257839246999552